David J. Marmion

581 total citations
15 papers, 401 citations indexed

About

David J. Marmion is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, David J. Marmion has authored 15 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 9 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in David J. Marmion's work include Parkinson's Disease Mechanisms and Treatments (9 papers), RNA regulation and disease (4 papers) and Neurological disorders and treatments (4 papers). David J. Marmion is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), RNA regulation and disease (4 papers) and Neurological disorders and treatments (4 papers). David J. Marmion collaborates with scholars based in United States, Sweden and Belgium. David J. Marmion's co-authors include Jeffrey H. Kordower, Christopher W. McMahon, Jeffrey H. Kordower, Yaping Chu, Woong-Jai Won, Ashley S. Harms, Asta Jurkuvenaite, Gregory P. Williams, David G. Standaert and Aubrey M. Schonhoff and has published in prestigious journals such as Annals of Neurology, Neuroscience and Acta Neuropathologica.

In The Last Decade

David J. Marmion

13 papers receiving 386 citations

Peers

Countries citing papers authored by David J. Marmion

Since Specialization

Citations

This map shows the geographic impact of David J. Marmion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Marmion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Marmion more than expected).

Fields of papers citing papers by David J. Marmion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Marmion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Marmion. The network helps show where David J. Marmion may publish in the future.

Co-authorship network of co-authors of David J. Marmion

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Marmion. A scholar is included among the top collaborators of David J. Marmion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Marmion. David J. Marmion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Assessment of complementary white matter microstructural changes and grey matter atrophy in the 6-OHDA-induced model of Parkinson’s disease 2025 ·Neuroscience ·Maurizio Bergamino, (unknown), Ivette M. Sandoval, David J. Marmion, Christopher Bishop, Fredric P. Manfredsson, Ashley M. Stokes	1
2	Long-Term Engraftment of Cryopreserved Human Neurons for In Vivo Disease Modeling in Neurodegenerative Disease 2025 ·Biology ·David J. Marmion, Peter Deng, (unknown), Rachel L. Lewis, Lutz Harms, (unknown), Jan A. Nolta, Jeffrey H. Kordower, Kyle D. Fink, Dustin R. Wakeman	0
3	Alterations in functional and structural connectivity in the 6-OHDA-induced Parkinsonian rat model 2025 ·Frontiers in Neuroscience ·Shunwei Zhu, Maurizio Bergamino, (unknown), Ivette M. Sandoval, David J. Marmion, Christopher Bishop, Fredric P. Manfredsson, Ashley M. Stokes	0
4	Engineered AAV capsid transport mutants overcome transduction deficiencies in the aged CNS 2024 ·Molecular Therapy — Nucleic Acids ·Ivette M. Sandoval, Christy M. Kelley, (unknown), Kathy Steece‐Collier, David J. Marmion, Marcus Davidsson, Sean M. Crosson, Sanford L. Boye, Fredric P. Manfredsson	5
5	Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease 2022 ·npj Regenerative Medicine ·(unknown), David J. Marmion, Cayla A. Thompson, (unknown), Howard J. Federoff, Patrik Brundin, Virginia B. Mattis, Christopher W. McMahon, Jeffrey H. Kordower	48
6	Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies 2021 ·Journal of Parkinson s Disease ·Ivette M. Sandoval, David J. Marmion, (unknown), Fredric P. Manfredsson	14
7	A historical review of multiple system atrophy with a critical appraisal of cellular and animal models 2021 ·Journal of Neural Transmission ·David J. Marmion, Wouter Peelaerts, Jeffrey H. Kordower	11
8	Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9 2021 ·Gene Therapy ·(unknown), David J. Marmion, Jodi L. McBride, Fredric P. Manfredsson, David Butler, Anne Messer, Jeffrey H. Kordower	26
9	Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease 2020 ·Neurobiology of Disease ·David J. Marmion, (unknown), (unknown), (unknown), Milton H. Werner, Erwan Bézard, Deniz Kirik, Thomas J. McCown, Steven J. Gray, Jeffrey H. Kordower	17
10	T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease 2020 ·Acta Neuropathologica ·Gregory P. Williams, David J. Marmion, Aubrey M. Schonhoff, Asta Jurkuvenaite, Woong-Jai Won, David G. Standaert, Jeffrey H. Kordower, Ashley S. Harms	70
11	Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivo 2020 ·Stem Cells Translational Medicine ·(unknown), David J. Marmion, (unknown), Cayla A. Thompson, (unknown), Patrik Brundin, Dustin R. Wakeman, Christopher W. McMahon, Jeffrey H. Kordower	16
12	Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates 2017 ·Acta Neuropathologica Communications ·Ronald J. Mandel, David J. Marmion, Deniz Kirik, Yaping Chu, Clifford Heindel, Thomas J. McCown, Steven J. Gray, Jeffrey H. Kordower	37
13	α-Synuclein nonhuman primate models of Parkinson’s disease 2017 ·Journal of Neural Transmission ·David J. Marmion, Jeffrey H. Kordower	30
14	Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo 2017 ·Stem Cell Reports ·Dustin R. Wakeman, (unknown), David J. Marmion, Christopher W. McMahon, Grant T. Corbett, (unknown), Junyi Ma, (unknown), Zhong Xie, Tamara Perez‐Rosello, Jaime N. Guzmán, D. James Surmeier, Jeffrey H. Kordower	67
15	Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient 2016 ·Annals of Neurology ·Jeffrey H. Kordower, Christopher G. Goetz, Yaping Chu, Glenda M. Halliday, Daniel A. Nicholson, Timothy F. Musial, David J. Marmion, A. Jon Stoessl, Vesna Sossi, Thomas B. Freeman, C. Warren Olanow	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact